BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 26830615)

  • 21. Epidemiology of contrast material-induced nephropathy in the era of hydration.
    Balemans CE; Reichert LJ; van Schelven BI; van den Brand JA; Wetzels JF
    Radiology; 2012 Jun; 263(3):706-13. PubMed ID: 22535561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute Kidney Injury After Intravenous Versus Intra-Arterial Contrast Material Administration in a Paired Cohort.
    McDonald JS; Leake CB; McDonald RJ; Gulati R; Katzberg RW; Williamson EE; Kallmes DF
    Invest Radiol; 2016 Dec; 51(12):804-809. PubMed ID: 27299579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iodixanol versus iopromide in cancer patients: Evidence from a randomized clinical trial.
    Terrenato I; Sperati F; Musicco F; Pozzi AF; di Turi A; Caterino M; de Lutio di Castelguidone E; Setola SV; Bellomi M; Neumaier CE; Conti L; Cigliana G; Merola R; Antenucci A; Orlandi G; Giordano A; Barba M; Canitano S
    J Cell Physiol; 2018 Mar; 233(3):2572-2580. PubMed ID: 28777459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial.
    Jo SH; Youn TJ; Koo BK; Park JS; Kang HJ; Cho YS; Chung WY; Joo GW; Chae IH; Choi DJ; Oh BH; Lee MM; Park YB; Kim HS
    J Am Coll Cardiol; 2006 Sep; 48(5):924-30. PubMed ID: 16949481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subclinical Contrast-Induced Acute Kidney Injury in Patients Undergoing Cerebral Computed Tomography.
    Breglia A; Godi I; Virzì GM; Guglielmetti G; Iannucci G; De Cal M; Brocca A; Carta M; Giavarina D; Ankawi G; Passannante A; Yun X; Biolo G; Ronco C
    Cardiorenal Med; 2020; 10(2):125-136. PubMed ID: 32036364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High incidence of nephropathy in neurosurgical patients after intra-arterial administration of low-osmolar and iso-osmolar contrast media.
    Serafin Z; Karolkiewicz M; Gruszka M; Strózecki P; Lasek W; Odrowaz-Sypniewska G; Manitius J; Beuth W
    Acta Radiol; 2011 May; 52(4):422-9. PubMed ID: 21498279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Iso-osmolar radio contrast iodixanol in patients with chronic kidney disease.
    Tadros GM; Malik JA; Manske CL; Kasiske BL; Dickinson SE; Herzog CA; Wilson RF; Das G; Panetta CJ
    J Invasive Cardiol; 2005 Apr; 17(4):211-5. PubMed ID: 15831975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of contrast-induced nephrotoxicity of iodixanol and iopromide in patients with renal insufficiency undergoing coronary angiography.
    Shin DH; Choi DJ; Youn TJ; Yoon CH; Suh JW; Kim KI; Cho YS; Cho GY; Chae IH; Kim CH
    Am J Cardiol; 2011 Jul; 108(2):189-94. PubMed ID: 21545991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention.
    Nie B; Cheng WJ; Li YF; Cao Z; Yang Q; Zhao YX; Guo YH; Zhou YJ
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):958-65. PubMed ID: 19021282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Iodixanol versus low-osmolar contrast media for prevention of contrast induced nephropathy: meta-analysis of randomized, controlled trials.
    From AM; Al Badarin FJ; McDonald FS; Bartholmai BJ; Cha SS; Rihal CS
    Circ Cardiovasc Interv; 2010 Aug; 3(4):351-8. PubMed ID: 20647563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of contrast-induced nephropathy in patients with multiple myeloma undergoing contrast-enhanced CT.
    Pahade JK; LeBedis CA; Raptopoulos VD; Avigan DE; Yam CS; Kruskal JB; Pedrosa I
    AJR Am J Roentgenol; 2011 May; 196(5):1094-101. PubMed ID: 21512075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of contrast-induced nephropathy in patients with chronic renal insufficiency undergoing multidetector computed tomographic angiography treated with preventive measures.
    El-Hajjar M; Bashir I; Khan M; Min J; Torosoff M; DeLago A
    Am J Cardiol; 2008 Aug; 102(3):353-6. PubMed ID: 18638601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of iodixanol and ioversol for the prevention of contrast-induced nephropathy in diabetic patients after coronary angiography or angioplasty.
    Hernández F; Mora L; García-Tejada J; Velázquez M; Gómez-Blázquez I; Bastante T; Albarrán A; Andreu J; Tascón J
    Rev Esp Cardiol; 2009 Dec; 62(12):1373-80. PubMed ID: 20038403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preprocedure and Postprocedure Predictive Values of Serum β2-Microglobulin for Contrast-Induced Nephropathy in Patients Undergoing Coronary Computed Tomography Angiography: A Comparison With Creatinine-Based Parameters and Cystatin C.
    Li S; Zheng Z; Tang X; Peng L; Luo Y; Dong R; Zhao Y; Liu J
    J Comput Assist Tomogr; 2015; 39(6):969-74. PubMed ID: 26248154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of Safety Guidelines on the Use of Iodinated Contrast Material: Conundrum Continued.
    Nijssen EC; Nelemans PJ; Rennenberg RJ; van Ommen V; Wildberger JE
    Invest Radiol; 2018 Oct; 53(10):616-622. PubMed ID: 29762257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of contrast-medium-induced nephropathy in high-risk patients undergoing MDCT--a pooled analysis of two randomized trials.
    Thomsen HS; Morcos SK
    Eur Radiol; 2009 Apr; 19(4):891-7. PubMed ID: 19002467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preventive effect of oral nicorandil on contrast-induced nephropathy in patients with renal insufficiency undergoing elective cardiac catheterization.
    Fan Y; Wei Q; Cai J; Shi Y; Zhang Y; Yao L; Wang X; Lin S; Li Y; Lv J; Zhou B; Du R
    Heart Vessels; 2016 Nov; 31(11):1776-1782. PubMed ID: 26874946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of contrast-induced nephropathy on cardiac outcomes after use of nonionic isosmolar contrast media during coronary procedure.
    Cho JY; Jeong MH; Hwan Park S; Kim IS; Park KH; Sim DS; Yoon NS; Yoon HJ; Park HW; Hong YJ; Kim JH; Ahn Y; Cho JG; Park JC; Kang JC
    J Cardiol; 2010 Nov; 56(3):300-6. PubMed ID: 20708903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study.
    Mehran R; Nikolsky E; Kirtane AJ; Caixeta A; Wong SC; Teirstein PS; Downey WE; Batchelor WB; Casterella PJ; Kim YH; Fahy M; Dangas GD
    JACC Cardiovasc Interv; 2009 May; 2(5):415-21. PubMed ID: 19463464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal tolerability of iopromide and iodixanol in 562 renally impaired patients undergoing cardiac catheterisation: the DIRECT study.
    Chen Y; Hu S; Liu Y; Zhao R; Wang L; Fu G; He Q; Su X; Zheng Y; Qi X; Liu H; Wang J; Gao W; Wang M; Liu S; Zheng X; He B; Yang P; Zhou S; Gao C; Qiu C
    EuroIntervention; 2012 Nov; 8(7):830-8. PubMed ID: 23045301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.